360-60-1

Basic information

• Product Name: 2,3-Diaminobenzotrifluoride 97%
• Synonyms: 2,3-Diaminobenzotrifluoride 97%;3-(Trifluoromethyl)benzene-1,2-diamine;3-(trifluoroMethyl)benzene-1;2,3-Diaminobenzotrifluoride, 3-(Trifluoromethyl)phenylene-1,2-diamine;3-(Trifluoromethyl)benzene-1,2-diamine 97%;3-(Trifluoromethyl)benzene-1,2-diamine97%;2,3-Diaminobenzotrifluoride97%
• CAS NO: 360-60-1
• Molecular Formula: C₇H₇F₃N₂
• Molecular Weight: 176
• Mol File: 360-60-1.mol
• Article Data: 8

Chemical Properties

• Melting Point: 41 °C
• Boiling Point: 125 °C(Press: 14 Torr)
• Appearance: /
• Density: 1.381±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 2.94±0.10(Predicted)
• CAS DataBase Reference: 2,3-Diaminobenzotrifluoride 97%(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3-Diaminobenzotrifluoride 97%(360-60-1)
• EPA Substance Registry System: 2,3-Diaminobenzotrifluoride 97%(360-60-1)

Safety Data

• Hazardous Substances Data: 360-60-1(Hazardous Substances Data)

Usage

General Description

2,3-Diaminobenzotrifluoride, also known as 2,3-DABTF, is a chemical compound that is commonly used in the production of polymers and pharmaceuticals. It is a white crystalline substance with a purity of 97%, making it suitable for a variety of industrial applications. 2,3-DABTF is a versatile chemical that can be used as a building block in the synthesis of various compounds, including dyes, agrochemicals, and metal chelators. It is also known for its strong nucleophilic properties and is often used as a reagent in organic synthesis reactions. Additionally, 2,3-DABTF is considered to be relatively stable and safe to handle, making it a popular choice for chemical processes in research and industrial settings.

Upstream product

• 24821-19-0 2-Nitro-6-trifluormethyl-benzamid 
• 603-11-2 3-nitrophthalic acid 
• 386-71-0 2-nitro-3-(trifluoromethyl)aniline 

Downstream Products

• 1221265-61-7 2-(4-methoxyphenyl)-5-(trifluoromethyl)-quinoxaline 
• 1221265-62-8 2-(4-methoxyphenyl)-8-(trifluoromethyl)-quinoxaline 
• 1221265-59-3 4-[3-ethyl-5-(trifluoromethyl)quinoxalin-2-yl]phenol 
• 1221265-60-6 C₁₇H₁₃F₃N₂O 
• 1221265-57-1 2-(4-chlorophenyl)-3-methyl-5-(trifluoromethyl)quinoxaline 
• 1221265-58-2 3-(4-chlorophenyl)-2-methyl-5-(trifluoromethyl)quinoxaline 
• 1065479-88-0 N-((S)-1-(3-(2-chlorophenyl)-5-(trifluoromethyl)quinoxalin-2-yl)ethyl)-9H-purin-6-amine 
• 1065480-17-2 N-((R)-1-(3-(2-chlorophenyl)-5-(trifluoromethyl)quinoxalin-2-yl)ethyl)-9H-purin-6-amine 
• 1065483-32-0 N-(1-(3-(2-chlorophenyl)-5-(trifluoromethyl)quinoxalin-2-yl)ethyl)-9H-purin-6-amine 
• 1065482-59-8 2-(1-(3-(2-chlorophenyl)-5-(trifluoromethyl)quinoxalin-2-yl)ethyl)-isoindoline-1,3-dione 
• 1065482-60-1 1-(3-(2-chlorophenyl)-5-(trifluoromethyl)quinoxalin-2-yl)ethanamine 
• 1065482-58-7 1-(3-(2-chlorophenyl)-5-(trifluoromethyl)quinoxalin-2-yl)ethanol 
• 1065482-56-5 2-(bromomethyl)-3-(2-chlorophenyl)-5-(trifluoromethyl)quinoxaline 
• 1065482-57-6 3-(2-chlorophenyl)-5-(trifluoromethyl)quinoxaline-2-carbaldehyde 

Relevant articles and documents

SUBSTITUTED BENZIMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS

The invention provides substituted benzimidazole carboxamides and related compounds, compositions containing such compounds, medical kits, and methods for using such compounds and compositions to treat a medical disorder, e.g., cancer, lysosomal storage disorder, neurodegenerative disorder, inflammatory disorder, in a patient.

Chiral linker-bridged bis-N-heterocyclic carbenes: Design, synthesis, palladium complexes, and catalytic properties

A series of chiral bis(benzimidazolium) salts 10-19 with (1R,2R)-cyclohexene, (1R,2R)-diphenylethylene and (aR)-binaphthylene linkers have been designed and synthesized in 30-94% yield. Ten chiral bis(NHC) palladium complexes 20-28 have been synthesized and characterized by NMR, HRMS, elemental analysis and further confirmed by X-ray single crystal analysis. These bis(NHC)-Pd complexes showed obviously different catalytic properties in the asymmetric Suzuki-Miyaura coupling reactions. The (1R,2R)-cyclohexene-bridged bis(NHC)-Pd complex, (R,R)-23, achieved the highest yield of 90%, while complex (aR)-28, with a binaphthylene linker, showed the best enantioselectivity of 60 ee%. The structural analysis of these complexes suggested that such difference of catalytic performance has a close relationship with their coordination surroundings around metal centres.

DIHYDROOROTATE DEHYDROGENASE INHIBITORS

The invention relates to compounds of formula (I) wherein R1, R2, X1, X2, Y, Ra, Rb, Q have the meanings given in claim 1. The compounds are useful e.g. in the treatment of autoimmune disorders, such as multiple sclerosis and also in the treatment of cancer disorders.